You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor neoantigens

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Gastric Cancer Associated Neoantigens

Not yet recruiting
  • Gastric Cancer
  • Neoantigens
  • ratio of predicted neoantigens
  • Ho Chi Minh City, Vietnam
    University Medical Center Ho Chi Minh City
Aug 9, 2022

Esophageal Cancer Associated Neoantigens

Not yet recruiting
  • Esophageal Cancer
  • Neoantigen
  • ratio of predicted neoantigens
  • Ho Chi Minh City, Vietnam
    University Medical Center Ho Chi Minh City
Aug 9, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colonic Neoplasms
  • Colorectal Neoplasms
  • Detroit, Michigan
  • +2 more
Aug 1, 2022

A Screening Study Targeting Tumor-specific Antigens

Recruiting
  • Metastatic Colorectal Cancer
  • Stage II/III Colon Cancer
  • blood collection for research (next generation sequencing [NGS])
  • +2 more
  • Los Angeles, California
  • +6 more
Dec 2, 2021

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

Not yet recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +2 more
  • CyPep-1
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Pittsburgh, Pennsylvania
  • +18 more
Nov 21, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Tumor Budding in Colorectal Cancer Under Different MMR Status

Completed
  • Tumor Budding
  • Rectal Cancer
  • total mesorectal exicision
  • Guangzhou, Guangdong, China
    Department of colorectal surgery, the Sixth Affiliated Hospital,
Nov 8, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,

Recruiting
  • Endocrine/Neuroendocrine
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colorectal Neoplasms
  • Gilbert, Arizona
  • +46 more
Jan 31, 2023

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Recurrent Hepatocellular Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Oct 7, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

Ovarian Cancer, Oligometastatic Disease, Recurrent Ovary Cancer Trial (Stereotactic body radiotherapy)

Recruiting
  • Ovarian Neoplasms
  • +2 more
  • Stereotactic body radiotherapy
  • Campobasso, CB, Italy
  • +7 more
Sep 23, 2022

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023